Cancer-Associated Thrombosis: An Overview of Mechanisms, Risk Factors, and Treatment.

作者: Norbaini Abdol Razak , Gabrielle Jones , Mayank Bhandari , Michael Berndt , Pat Metharom

DOI: 10.3390/CANCERS10100380

关键词: Cancer cellVenous thromboembolismCancer associated thrombosisMedicineOncologyInternal medicineComplicationThrombosisIncreased riskChemotherapyCancer

摘要: Cancer-associated thrombosis is a major cause of mortality in cancer patients, the most common type being venous thromboembolism (VTE). Several risk factors for developing …

参考文章(145)
Magid Amer, Cancer-associated thrombosis: clinical presentation and survival. Cancer management and research. ,vol. 5, pp. 165- 178 ,(2013) , 10.2147/CMAR.S47094
M. E. T. TESSELAAR, F. P. H. T. M. ROMIJN, I. K. VAN DER LINDEN, F. A. PRINS, R. M. BERTINA, S. OSANTO, Microparticle-associated tissue factor activity: a link between cancer and thrombosis? Journal of Thrombosis and Haemostasis. ,vol. 5, pp. 520- 527 ,(2007) , 10.1111/J.1538-7836.2007.02369.X
Abdul Hakkim, Tobias A Fuchs, Nancy E Martinez, Simone Hess, Heino Prinz, Arturo Zychlinsky, Herbert Waldmann, Activation of the Raf-MEK-ERK pathway is required for neutrophil extracellular trap formation Nature Chemical Biology. ,vol. 7, pp. 75- 77 ,(2011) , 10.1038/NCHEMBIO.496
Rudolf Pihusch, Gudrun Danzl, Michael Scholz, Detlev Harich, Markus Pihusch, Peter Lohse, Erhard Hiller, Impact of thrombophilic gene mutations on thrombosis risk in patients with gastrointestinal carcinoma Cancer. ,vol. 94, pp. 3120- 3126 ,(2002) , 10.1002/CNCR.10590
Tufia C. Haddad, Edward W. Greeno, Chemotherapy-induced thrombosis Thrombosis Research. ,vol. 118, pp. 555- 568 ,(2006) , 10.1016/J.THROMRES.2005.10.015
Bojing Shao, Mark G. Wahrenbrock, Longbiao Yao, Tovo David, Shaun R. Coughlin, Lijun Xia, Ajit Varki, Rodger P. McEver, Carcinoma mucins trigger reciprocal activation of platelets and neutrophils in a murine model of Trousseau syndrome Blood. ,vol. 118, pp. 4015- 4023 ,(2011) , 10.1182/BLOOD-2011-07-368514
PIOTR M. CZAYKOWSKI, MALCOLM J. MOORE, IAN F. TANNOCK, HIGH RISK OF VASCULAR EVENTS IN PATIENTS WITH UROTHELIAL TRANSITIONAL CELL CARCINOMA TREATED WITH CISPLATIN BASED CHEMOTHERAPY The Journal of Urology. ,vol. 160, pp. 2021- 2024 ,(1998) , 10.1016/S0022-5347(01)62232-8
Paul D. Stein, Afzal Beemath, Frederick A. Meyers, Elias Skaf, Julia Sanchez, Ronald E. Olson, Incidence of Venous Thromboembolism in Patients Hospitalized with Cancer The American Journal of Medicine. ,vol. 119, pp. 60- 68 ,(2006) , 10.1016/J.AMJMED.2005.06.058